GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » Policy Acquisition Expense

Vivoryon Therapeutics NV (FRA:05Y) Policy Acquisition Expense


View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Vivoryon Therapeutics NV (FRA:05Y) Business Description

Traded in Other Exchanges
Address
Weinbergweg 22, Halle, SN, DEU, 06120
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.